Bright Minds Biosciences Inc (DRUG)
Healthcare
Biotechnology
73.30 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Bright Minds Biosciences Inc (DRUG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -9.5 million CAD. Tick rows to compare them in a chart.
All figures in millions of CAD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.7 | -1.2 | -0.8 | -0.8 | 0.2 | -0.5 | -1.5 | -2.4 | -3.5 | -1.3 | -5.8 | -9.5 | -20 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.2 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | 1.3 | 1.1 | 1.3 | 1.2 | 4.9 | |
| -0.3 | -0.3 | 0.6 | -0.5 | -0.2 | 0.1 | -0.1 | -0.1 | -0.4 | 1.2 | -1.0 | 1.4 | 1.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 52 | 0.2 | 0.0 | 33 | 13 | 232 | 279 | |
| -1.5 | -1.4 | 0.0 | -0.8 | 0.3 | -0.5 | 52 | -2.2 | -4.3 | 32 | 6.1 | 219 | 252 | |
| -1.7 | -1.2 | -0.8 | -0.8 | 0.2 | -0.5 | -1.5 | -2.4 | -3.5 | -1.3 | -5.8 | -9.5 | -20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.